PERK/ISR inhibition has been found to relieve neurotoxicity in animal and cellular models of ALS (TDP43 and C9orf72) or other pathologies, such as prionic disease or vanishing white matter disease29,42,60,61. This evidence concerns the gene EIF2AK3 and amyotrophic lateral sclerosis.